VERTEX PHARMACEUTICALS INC 13G ANNUAL FILING

Company

VERTEX PHARMACEUTICALS INC / MA

Filed

February 14, 2012

Accession Number

0000053417-12-000119

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →